Infection dynamics of Cryptosporidium parvum in ICR outbred suckling mice

Folia Parasitologica

Volumn 43, Issue 2, 1996, Pages 101-106

  Upton, Steve J ^a   Gillock, Hilary H ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

age; Apicomplexa; coccidia; Cryptosporidium parvum; in vivo; suckling mouse; weight

Indexed keywords

AGE; ANIMAL; ARTICLE; BODY WEIGHT; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE MODEL; DRUG SCREENING; FEMALE; GROWTH, DEVELOPMENT AND AGING; INSTITUTE FOR CANCER RESEARCH MOUSE; INTESTINE; METHODOLOGY; MOUSE; PARASITOLOGY; SUCKLING;

AGE FACTORS; ANIMALS; ANIMALS, SUCKLING; BODY WEIGHT; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; INTESTINES; MICE; MICE, INBRED ICR;

ANIMALIA; APICOMPLEXA; COCCIDIA; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM;

EID: 0029769643     PISSN: 00155683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. ANDREWS E. J., BENNETT B. T., CLARK D. J., HOUPT K. A., PASCOE P. J., ROBINSON G. W., BOYCE J. R. 1993: Report of the AVMA panel on euthanasia. J. Am. Vet. Med. Assoc. 202: 229-249.
2. BJORNEBY J. M., HUNSAKER B. D., RIGGS M. W., PERRYMAN L. E. 1991: Monoclonal antibody immunotherapy in Nude mice persistently infected with Cryptosporidium parvum. Infect. Immun. 59: 1172-1176.
3. BLAGBURN B. L., SUNDERMANN C. A., LINDSAY D. S., HALL J. E., TIDWELL R. R. 1991: Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss mice by polyether ionophores and aromatic amides. Antimic. Agents Chemother. 35: 1520-1523.
4. BRASSEUR P., FAVENNEC L., LEMÉTEIL D., ROUSSEL F., BALLET J. J. 1994: An immunosuppressed rat model for evaluation of anti-Cryptosporidium activity of sinefungin. Folia Parasitol. 41: 13-16.
5. BRASSEUR P., LEMÉTEIL D., BALLET J. J. 1988: Rat model for human cryptosporidiosis. J. Clin. Microbiol. 26: 1037-1039.
6. BRASSEUR P., LEMÉTEIL D., BALLET J. J. 1991: Anti-cryptosporidial drug activity screened with an immunosuppressed rat model. J. Euk. Microbiol. 38: 230s-231s.
7. BRASSEUR P., LEMÉTEIL D., BALLET J J. 1993: Curative and preventive anti-Cryptosporidium activities of sinefungin in an immunosuppressed adult rat model. Antimicrob. Agents Chemother. 37: 889-892.
8. BURAUD M., KAPEL N., BENHAMOU Y., SAVEL J., GOBERT J. G. 1995: A high-yield outbred suckling mouse model of cryptosporidiosis. Parasite 2: 81-84
9. CAMA V. A., MARSHALL M. M., SHUBITZ L. F., ORTEGA Y. R., STERLING C. R. 1994: Treatment of acute and chronic Cryptosporidium parvum infections in mice using clarithromycin and 14-OH clarithromycin. J. Euk. Microbiol. 41: 25s.
10. + cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infec. Immun. 61: 3928-3932.
11. CHEN W., HARP J. A., HARMSEN A. G., HAVELL E. A. 1993b: Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficiency mice. Infec. Immun. 61: 3548-3551
12. CHUI D. W., OWEN R. L. 1994: AIDS and the gut. J. Gastroent. Hepatol. 9: 291-303.
13. CURRENT W. L., GARCIA L. S. 1991: Cryptosporidiosis. Clin. Microbiol. Rev. 4: 325-358.
14. ENRIQUEZ F. J., STERLING C. R. 1991: Cryptosporidium infections in inbred strains of mice. J. Protozool. 38: 100s-102s.
15. ERNEST J. A., BLAGBURN B. L., LINDSAY D. S., CURRENT W. L. 1986: Infection dynamics of Cryptosporidium parvum (Apicomplexa: Cryptosporidiidae) in neonatal mice (Mus musculus). J. Parasitol. 72: 796-798.
16. FAYER R., ELLIS W. 1993: Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice. J. Parasitol. 79: 553-558.
17. FAYER R., ELLIS W. 1994: Qinghaosu (artemisinin) and derivitives fail to protect neonatal BALB/c mice against Cryptosporidium parvum (Cp) infection. J. Euk. Microbiol. 41: 41s.
18. FAYER R , SPEER C. A., DUBEY J. P. 1990: General biology of Cryptosporidium. In: J. P. Dubey, C. A. Speer, and R. Fayer (Eds.), Cryptosporidiosis of Man and Animals. CRC Press, Boca Raton, Florida, pp. 1-29.
19. FINCH G. R., DANIELS C. W., BLACK E. K., SCHAEFFER F. W. III, BELOSEVIC M. 1993: Dose response of Cryptosporidium parvum in outbred neonatal CD-1 mice. Appl. Environ. Microbiol. 59: 3661-3665.
20. HEINE J., MOON H. W., WOODMANSEE D. B. 1984: Persistent Cryptosporidium infection in congenitally athymic (nude) mice. Infect. Immun. 43: 856-859.
21. KIM C. W. 1987a: Chemotherapeutic effects of arprinocid in experimental cryptosporidiosis. J. Parasitol. 73: 663-666.
22. KIM C. W. 1987b: Cryptosporidium sp.: experimental infection in Syrian golden hamsters. Exp. Parasitol. 63: 243-246.
23. KIMATA I., UNI S., ISEKI M. 1991: Chemotherapeutic effect of azithromycin and lasalocid on Cryptosporidium infection in mice. J. Protozool. 38: 232s-233s.
24. KOUDELA B., HEŘMÁNEK J. 1993: Nonspecific immunomodulation influences the course and location of Cryptosporidium parvum infection in neonatal BALB/c mice. Ann. Parasitol. Hum. Comp. 68: 3-10.
25. KUHLS T. L., GREENFIELD R. A., MOSIER D. A., CRAWFORD D. L., JOYCE W. A. 1992. Cryptosporidiosis in adult and neonatal mice with severe combined immunodeficiency. J. Comp. Pathol. 106: 399-410.
26. KWA B. H., MOYAD M., PENTELLA M. A., ROSE J. B. 1993: A nude mouse model as an in vivo infectivity assay for cryptosporidiosis. Wat. Sci. Tech. 27: 65-68.
27. LEITCH G. J., HE Q. 1994: Putative anticryptosporidial agents tested with an immunodeficient mouse model. Antimicrob. Agents Chemother. 38: 865-867.
28. LEMÉTEIL D., ROUSSEL F., FAVENNEC L., BALLET J. J., BRASSEUR P. 1993: Assessment of candidate anticryptosporidial agents in an immunosuppressed rat model. J. Infect. Dis. 167: 766-768.
29. MEAD J. R., ARROWOOD M. J., SIDWELL R. W., HEALEY M. C. 1991: Chronic Cryptosporidium parvum infection in congenitally immunodeficient SCID and nude mice. J. Infect. Dis. 163: 1297-1304.
30. MEAD J. R., YOU X., PHARR J. E., BELENKAYA Y., ARROWOOD M. J., FALLON M. T., SCHINAZ R. F. 1995: Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosis. Antimicrob. Agents Chemother. 39: 854-858.
31. MOORE J. A., BLAGBURN B. L., LINDSAY D. S. 1988: Cryptosporidiosis in animals including humans. Comp. Cont. Educ. 10: 275-286.
32. NOVAK S. M., STERLING C. R. 1991: Susceptibility dynamics in neonatal BALB/c mice infected with Cryptosporidium parvum. J. Protozool. 38: 102s-104s
33. OZAKI C. K., CHU S. W., WALKER W. A. 1989: Age-related changes in chemical composition and physical properties of mucus glycoproteins from rat small intestine. Biochim. Biophys. Acta 991: 243-247.
34. PERRYMAN L. E., BJORNEBY J. M. 1991: Immunotherapy of cryptosporidiosis in immunodeficient animal models. J. Protozool. 38: 98s-100s.
35. PERRYMAN L. E., KEGERREIS K. A., MASON P. H. 1993: Effect of orally administered monoclonal antibody on persistent Cryptosporidium parvum infection in SCID mice. Infect. Immun. 61: 4906-4908.
36. PETRY F., ROBINSON H. A., McDONALD V. 1995: Murine infection model for maintenance and amplification of Cryptosporidium parvum oocysts. J. Clin. Microbiol. 33: 1922-1924.
37. RASMUSSEN K. R., HEALEY M. C. 1992a: Cryptosporidium parvum: experimental infections in aged Syrian golden hamsters. J. Infect. Dis. 165: 769-772.
38. RASMUSSEN K. R., HEALEY M. C. 1992b: Dehydroepiandrosterone-induced reduction of Cryptosporidium parvum infections in aged Syrian golden hamsters. J. Parasitol. 78: 554-557.
39. RASMUSSEN K. R., HEALEY M. C. 1992c: Experimental Cryptosporidium parvum infections in immunosuppressed adult mice. Infect. Immun. 60: 1648-1652.
40. RASMUSSEN K. R., HEALEY M. C., CHENG L., YANG S. 1995: Effects of dehydroepiandrosterone in immunosuppressed adult mice infected with Cryptosporidium parvum. J. Parasitol. 81: 429-433.
41. RASMUSSEN K. R., MARTIN E. G., ARROWOOD M. J., HEALEY M. C. 1991: Effects of dexamethasone and dehydroepiandrosterone in immunosupressed rats infected with Cryptosporidium parvum. J. Protozool. 38: 157s-159s.
42. REHG J. E. 1991a: Anticryptosporidial acitivty is associated with specific sulfonamides in immunosuppressed rats. J. Parasitol. 77: 238-240.
43. REHG J. E. 1991b: Activity of azithromycin against cryptosporidia in immunosuppressed rats. J. Infect. Dis. 163: 1293-1296.
44. REHG J. E. 1991c: Anti-cryptosporidial activity of macrolides in immunosuppressed rats. J. Protozool. 38: 228s-230s.
45. REHG J. E. 1993: Anticryptosporidial activity of lasalocid and other ionophorous antibiotics in immunosuppressed rats. J. Infect. Dis. 168: 1566-1569.
46. REHG J. E. 1994a: A comparison of anticryptosporidial activity of paromomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats. J. Infect. Dis. 170: 934-938.
47. REHG J. E. 1994b: New potential therapies for cryptosporidiosis: an analysis of variables affecting drug efficacy. Folia Parasitol. 41: 23-26.
48. REHG J. E. 1995: The activity of halofuginone in immunosuppressed rats infected with Cryptosporidium parvum. J. Antimicrob. Agents Chemother. 35: 391-397.
49. REHG J. E., HANCOCK M. L. 1990: Effectiveness of arprinocid in the reduction of cryptosporidial activity in immunosuppressed rats. Am. J. Vet. Res. 51: 1668-1670.
50. REHG J. E., HANCOCK M. L., WOODMANSEE D. B. 1987: Characterization of cyclophosphamide-rat model of cryptosporidiosis. Infect. Immun. 55: 2669-2674.
51. REHG J. E., HANCOCK M. L., WOODMANSEE D. B. 1988a: Characterization of a dexamethasone-treated rat model of cryptosporidial infection. J. Infect. Dis. 158: 1406-1407.
52. REHG J. E., HANCOCK M. L., WOODMANSEE D. B. 1988b: Anticryptosporidial activity of sulfadimethoxine. Antimicrob. Agents Chemother. 32: 1907-1908.
53. RIGGS M. W., PERRYMAN L. E. 1987: Infectivity and neutralization of Cryptosporidium parvum sporozoites. Infect. Immun. 55: 2081-2087.
54. ROSSI P., POZIO E., BESSE M. G., GOMEZ MORALES M. A., LA ROSA G. 1990: Expenmental cryptosporidiosis in hamsters. J. Clin. Microbiol. 28: 356-357.
55. ROUSSEL F., LEMÉTEIL D., FAVENNEC L., TAYOT J., BALLET J. J., BRASSEUR P. 1995: Respiratory tract cryptosporidiosis in immunosuppressed rat is associated with an epithelial metaplasia. Parasite 2: 85-87.
56. SHUB M. D., PANG K. Y., SWANN D. A., WALKER W. A. 1983: Age-related changes in chemical composition and physical properties of mucus glycoproteins from rat small intestine. Biochem. J. 215: 405-411.
57. SRIVASTAVA O. P., STEELE M. I., TORRES-PINEDO R. 1987: Maturational changes in terminal glycosylation of small intestinal microvillar proteins in the rat. Biochim. Biophys. Acta 914: 143-151.
58. STERLING C. R., ARROWOOD M. J 1992: Cryptosporidia. In: J. P. Kreier (Ed.), Parasitic Protozoa, 2nd ed. Academic Press, New York, pp. 159-225.
59. TAATJES D. J., ROTH J. 1990: Selective loss of sialic acid from rat small intestinal epithelial cells during postnatal development: demonstration with lectin-gold techniques. Eur. J. Cell Biol. 53: 255-266.
60. TAGHI-KILANI R., SEKLA L. 1987: Purification of Cryptosporidium oocysts and sporozoites by cesium chloride and percoll gradients. Am. J. Trop. Med. Hyg. 36: 505-508.
61. TILLEY M., UPTON S. J., CHRISP C. E. 1991a: A comparative study on the biology of Cryptosporidium sp. from guinea pigs and Cryptosporidium parvum (Apicomplexa). Can. J. Microbiol. 37: 949-952.
62. TILLEY M., UPTON S. J., FAYER R., BARTA J. R., CHRISP C. E., FREED P. S., BLAGBURN B. L., ANDERSON B. C., BARNARD B. C. 1991b: Identification of a 15-kilodalton surface glycoprotein on sporozoites of Cryptosporidium parvum. Infect. Immun. 59: 1002-1007.
63. TORRES-PINEDO R., MAHMOOD A. 1984: Postnatal changes in biosynthesis of microvillous membrane glycans of rat small intestine: I. Evidence of a developmental shift from terminal sialylation to fucosylation. Biochem. Biophys. Res. Commun. 125: 546-553.
64. TZIPORI S. R., CAMPBELL I., ANGUS K. W. 1982: The therapeutic effect of 16 antimicrobial agents on Cryptosporidium infection in mice. Aust. J. Exp. Biol. Med. Sci. 60: 187-190.
65. UNGAR B. L. P., BURRIS J. A , QUINN C. A., FINKELMAN F. D. 1990: New mouse models for Cryptosporidium infection in immunodeficient hosts. Infec. Immun. 58: 961-969
66. UPTON S. J., TILLEY M., NESTERENKO M. V., BRILLHART D. B. 1994: A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa). FEMS Microbiol. Lett. 118: 45-50.
67. VERDON R., POLIANSKI J., GAUDEBOUT C., MARCHE C., GARRY L., POCIDALO J. J. 1994: Evaluation of curative anticryptosporidial acitivty of paromomycin in a dexamethasone-treated rat model. Antimicrob. Agents Chemother. 38: 1681-1682.
68. WOODS K. M., NESTERENKO M. V., UPTON S. J. 1995: Development of a microtitre ELISA to quantitate development of Cryptosporidium parvum in vitro. FEMS Microbiol. Lett. 128: 89-91.
69. YANG S., HEALEY M. C. 1994: Development of patent gut infections in immunosuppressed adult C57BL/6N mice following intravenous inoculations of Cryptosporidium parvum oocysts. J. Euk. Microbiol. 41: 67.